The document outlines a sole-source justification for the acquisition of three Olympus CV-1500 Surgical Diagnostic Imaging Systems by the National Institutes of Health (NIH) Clinical Center. Due to urgent needs and the unique specifications of the existing system, no competition was deemed viable. The Clinical Center has utilized Olympus systems for over twenty years, thus ensuring consistency in training and integration with current protocols and applications, which involves significant patient safety considerations. The document cites Federal Acquisition Regulation (FAR) 13.106-1(b)(1) as the statutory authority for proceeding without full and open competition, emphasizing that only Olympus provides the required capabilities without risking patient safety or requiring additional training. The anticipated costs are noted to be fair and reasonable, aligned with industry standards and past procurements. Market research supported the sole-source claim, with no other vendors expressing interest in the acquisition. The recommendation highlights that continued use of Olympus technology will streamline operations and maintain high standards of care, ensuring that patient safety and operational efficiency are prioritized. Overall, this justification underlines the importance of maintaining consistency and reliability in critical medical systems.